{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:14:29Z","timestamp":1753888469678},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.ijcard.2006.01.007","type":"journal-article","created":{"date-parts":[[2006,5,5]],"date-time":"2006-05-05T06:20:11Z","timestamp":1146810011000},"page":"64-70","source":"Crossref","is-referenced-by-count":7,"title":["Eplerenone offsets cardiac and aortic adverse remodeling in spontaneously hypertensive rats"],"prefix":"10.1016","volume":"114","author":[{"given":"Adriana K.","family":"Burla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Fritsch","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wille","family":"Oigman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Mandarim-de-Lacerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2006.01.007_bib1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mhj.2002.129969","article-title":"Aldosterone: cardiovascular assault","volume":"144","author":"Struthers","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2006.01.007_bib2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.101.10.1130","article-title":"Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts","volume":"101","author":"Kawano","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.01.007_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.mnh.0000165889.60254.98","article-title":"Aldosterone and end-organ damage","volume":"14","author":"Brown","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ijcard.2006.01.007_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00004872-200301000-00029","article-title":"Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism","volume":"21","author":"Neves","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.ijcard.2006.01.007_bib5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2006.01.007_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11906-003-0012-2","article-title":"Aldosterone: a risk factor for vascular disease","volume":"5","author":"Neves","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ijcard.2006.01.007_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","article-title":"Pathophysiological effects of aldosterone in cardiovascular tissues","volume":"12","author":"Rocha","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ijcard.2006.01.007_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/hrt.2003.017368","article-title":"Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment","volume":"90","author":"Macdonald","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2006.01.007_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.0000138680.89536.A9","article-title":"Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure","volume":"110","author":"Mottram","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.01.007_bib10","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.01.007_bib11","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","article-title":"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology","volume":"57","author":"Delyani","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijcard.2006.01.007_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9149(03)00461-2","article-title":"Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension","volume":"92","author":"White","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2006.01.007_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.HYP.0000025146.19104.FE","article-title":"Efficacy of eplerenone added to renin\u2013angiotensin blockade in hypertensive patients","volume":"40","author":"Krum","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2006.01.007_bib14","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","article-title":"Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension","volume":"41","author":"White","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2006.01.007_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-5273(01)00483-1","article-title":"Exciting new drugs on the horizon\u2014eplerenone, a selective aldosterone receptor antagonist (SARA)","volume":"80","author":"Coats","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2006.01.007_bib16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2006.01.007_bib17","first-page":"57","article-title":"A simple method for volumetry of organs in quantitative stereology","volume":"26","author":"Scherle","year":"1970","journal-title":"Mikroskopie"},{"key":"10.1016\/j.ijcard.2006.01.007_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S0001-37652003000400006","article-title":"Stereological tools in biomedical research","volume":"75","author":"Mandarim-de-Lacerda","year":"2003","journal-title":"An Acad Bras Cienc"},{"key":"10.1016\/j.ijcard.2006.01.007_bib19","first-page":"727","article-title":"Effect of telmisartan on preexistent cardiac and renal lesions in spontaneously hypertensive mature rats","volume":"19","author":"Mandarim-de-Lacerda","year":"2004","journal-title":"Histol Histopathol"},{"issue":"Pt 2","key":"10.1016\/j.ijcard.2006.01.007_bib20","article-title":"The unbiased estimation of number and sizes of arbitrary particles using the disector","volume":"134","author":"Sterio","year":"1984","journal-title":"J Microsc"},{"key":"10.1016\/j.ijcard.2006.01.007_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2818.1981.tb01199.x","article-title":"Optimizing sampling efficiency of stereological studies in biology: or \u2018do more less well\u2019","volume":"121","author":"Gundersen","year":"1981","journal-title":"J Microsc"},{"key":"10.1016\/j.ijcard.2006.01.007_bib22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1699-0463.1988.tb00954.x","article-title":"The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis","volume":"96","author":"Gundersen","year":"1988","journal-title":"APMIS"},{"key":"10.1016\/j.ijcard.2006.01.007_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1006\/jmcc.2000.1129","article-title":"Induction of cardiac fibrosis by aldosterone","volume":"32","author":"Lijnen","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2006.01.007_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/hyp.39.2.614","article-title":"Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading","volume":"39","author":"Martinez","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2006.01.007_bib25","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.01.007_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/01.HYP.25.1.124","article-title":"Hypertrophy and hyperplasia of smooth muscle cells of small intramyocardial arteries in spontaneously hypertensive rats","volume":"25","author":"Amann","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2006.01.007_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF02255997","article-title":"The effects of spironolactone monotherapy on blood pressure and myocardial remodeling in spontaneously hypertensive rats: a stereological study","volume":"10","author":"Mandarim-de-Lacerda","year":"2003","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.ijcard.2006.01.007_bib28","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/01.RES.68.6.1560","article-title":"Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy","volume":"68","author":"Olivetti","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2006.01.007_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000028113","article-title":"Numerical density of cardiomyocytes in chronic nitric oxide synthesis inhibition","volume":"68","author":"Mandarim-de-Lacerda","year":"2000","journal-title":"Pathobiology"},{"key":"10.1016\/j.ijcard.2006.01.007_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s004280000276","article-title":"Influence of the chronic nitric oxide synthesis inhibition on cardiomyocytes number","volume":"437","author":"Pessanha","year":"2000","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ijcard.2006.01.007_bib31","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1006\/jmcc.2002.2115","article-title":"Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat","volume":"34","author":"De Angelis","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2006.01.007_bib32","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.RES.69.5.1185","article-title":"Cardiac myocyte necrosis induced by angiotensin II","volume":"69","author":"Tan","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2006.01.007_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/hy0102.100788","article-title":"Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II","volume":"39","author":"Gonzalez","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2006.01.007_bib34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1006\/jmcc.1996.0333","article-title":"Angiotensin II induces apoptosis of adult ventricular myocytes in vitro","volume":"29","author":"Kajstura","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2006.01.007_bib35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.yjmcc.2005.04.001","article-title":"Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo","volume":"39","author":"Burniston","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2006.01.007_bib36","first-page":"S65","article-title":"The time window of apoptosis: a new component in the therapeutic strategy for cardiovascular remodeling","volume":"14","author":"Hamet","year":"1996","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.ijcard.2006.01.007_bib37","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/en.141.10.3871","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2006.01.007_bib38","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000142858.44680.27","article-title":"Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice","volume":"110","author":"Garnier","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.01.007_bib39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Antialdosterone treatment and prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2006.01.007_bib40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000153800.09920.40","article-title":"Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload","volume":"111","author":"Kuster","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2006.01.007_bib41","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/01.HYP.0000128031.31572.a3","article-title":"Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats","volume":"43","author":"Endemann","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2006.01.007_bib42","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.HYP.37.6.1444","article-title":"ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats","volume":"37","author":"Park","year":"2001","journal-title":"Hypertension"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527306001641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527306001641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T16:15:56Z","timestamp":1555604156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527306001641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0167527306001641"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2006.01.007","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}